Toll Holdings Results Announced: Time to slim down

An appetite for growth has given Toll Holdings serious indigestion. New CEO Brian Kruger is making the right noises, but is it enough?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Toll Holdings Limted (ASX: TOL) was long likened to a corporate Pac-Man, seemingly eating everything in sight.

The business had a strategy which was designed to deliver success through growth – harnessing the economies of scale that come with increasing the company's size, and the opportunity to harness incremental profits through owning more parts of the logistics supply chain.

Revenue grows, margins fall

While sound in theory, the company hasn't been able to execute the strategy in a way that has delivered gains for shareholders. In fact, the acquisitions have seen Toll's return on capital fall from the mid-teens to single figures in the last few years, and return on equity halve from just over 20% in the 2006 financial year to 10% last year.

The reason can be traced straight to operating margins. Toll's business is  high-volume one, and margins were never going to be generous to start with, but after hitting a high of 13.8% of revenue in 2007, the most recently completed financial year saw operating margins fall to a 9-year low of 8.3% – in effect, a reduction of almost 40% per dollar of revenue. It's one thing for volumes to fall, but quite another to be systematically making less and less profit out of each dollar of sales that comes through the door.

EPS becomes the victim

Unfortunately for shareholders, that margin erosion has led to an earnings per share drop of close to 40% since 2007, even as sales grew 10%. For all of the hard work required to bring more customers through the door, it has counted for nought by the time that revenue hit the bottom line.

Disappointingly, that trend has continued into 2012. Toll's results released on February 23rd 2012 reported first-half sales of $4.4 billion, an increase of 5% on the same period of the prior year. Again, however, profits fell, this time by 8% to $161 million.

Retailing has undoubtedly suffered in the past couple of years and Toll is somewhat captive to that activity as it manages all or part of the supply chain for many large and small retail businesses. There has also been increasing pricing pressure, with carriers fighting harder for the lower freight volumes.

Poor returns on capital

The jury is out on whether this is a business that can improve with management focus, or simply one that has insufficient pricing power to achieve an adequate return for investors.

Fortunately for shareholders, Toll's new CEO, Brian Kruger seems to understand that Toll has simply become too big and has invested in businesses that do not provide an operating return for shareholders that is sufficiently above Toll's cost of capital.

Time for some decisions

Perhaps signalling his willingness to undo part of the previous management's strategy, Kruger has begun reporting the capital employed for each business, and the Australian Financial Review has reported that Toll is prepared to consider offloading underperforming assets.

Shareholders can only hope that includes some of Toll's capital-devouring divisions such as its Global Resources and Global Logistics units. If not, Toll is one business that investors should leave on the docks.

If you are looking for ASX investing ideas, look no further than "The Motley Fool's Top Stock for 2012." In this free report, Investment Analyst Dean Morel names his top pick for 2012…and beyond. Click here now to find out the name of this small but growing telecommunications company. But hurry – the report is free for only a limited period of time.

Scott Phillips Is The Motley Fool's feature columnist. Scott doesn't own shares in any company mentioned in this article. You can follow him on Twitter @TMFGilla. The Motley Fool's purpose is to educate, amuse and enrich investors.This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »